GlassScriptPhysician profile
Tracy L Cook
NPI 1457420911
$4,077.97
in general payments reported to CMS, 2019-2025
43 companies · $779 in 2025
The $779 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2020: $37.41 · 2021: $281 · 2022: $826 · 2023: $987 · 2024: $504 · 2025: $779.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,270.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $957.44 | 2019-2025 | Ubrelvy, Orilissa, Lo Loestrin Fe |
| Aspira Women'S Health INC | $486.46 | 2022-2024 | Ova1 |
| Mayne Pharma Commercial LLC | $305.49 | 2021-2025 | |
| Therapeuticsmd, INC. | $264.47 | 2019-2022 | |
| Hologic Sales and Service, LLC | $193.54 | 2019-2025 | Aptima |
| Gynesonics, INC. | $163.87 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Myriad Women'S Health, INC. | $141.95 | 2023 | Myrisk |
| Minerva Surgical, INC | $133.24 | 2022-2023 | |
| Pfizer INC. | $120.18 | 2022-2025 | |
| Agile Therapeutics, INC. | $106.48 | 2021-2022 | |
| Exeltis, USA INC. | $93.31 | 2021-2024 | Slynd |
| Amgen INC. | $92.87 | 2019-2025 | Evenity, Prolia, Prolia |
| Astellas Pharma US INC | $85.05 | 2023-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $74.78 | 2021-2024 | Paragard T 380a |
| Organon LLC | $60.35 | 2021-2025 | Jada System |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.